title: Similarity between hepatic graft-versus-host disease and primary biliary cirrhosis.
abstract: Similarities between hepatic graft-versus-host disease (GVHD) and primary biliary cirrhosis (PBC) have been reported recently. To examine this association, we studied 60 patients who underwent allogeneic bone marrow transplantation (BMT) consecutively at a single medical institution.Among the 60 patients, 12 developed hepatic GVHD after BMT and 48 did not. These two groups were compared with respect to various characteristics seen in PBC, such as autoantibodies, human leukocyte antigen (HLA) status, infection and inflammatory cytokines. The two groups showed a significant difference in HLA DR status. There was also a significant difference in the febrile period and in cytokine levels between the patients with hepatic GVHD and 12 other patients who had no complications after transplantation. These findings suggest that hepatic GVHD resembles PBC and that HLA DR features of PBC may also be risk factors for the onset of hepatic GVHD.
authors.affiliation: Division of Hematology and Oncology, Department of Internal Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.
authors.forename: Takeshi
authors.initials: T
authors.lastname: Wakae
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Takatsuka
authors.forename: Yoshifumi
authors.initials: Y
authors.lastname: Seto
authors.forename: Nobuo
authors.initials: N
authors.lastname: Iwata
authors.forename: Ako
authors.initials: A
authors.lastname: Mori
authors.forename: Masaya
authors.initials: M
authors.lastname: Okada
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Fujimori
authors.forename: Takahiro
authors.initials: T
authors.lastname: Okamoto
authors.forename: Eizo
authors.initials: E
authors.lastname: Kakishita
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Hara
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000097:blood; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D016022:Case-Control Studies; D016207:Cytokines / Q000097:blood; D005260:Female; D005334:Fever; D006086:Graft vs Host Disease / Q000097:blood / Q000209:etiology*; D006684:HLA-DR Antigens / Q000097:blood; D006801:Humans; D007371:Interferon-gamma / Q000097:blood; D015850:Interleukin-6 / Q000097:blood; D008105:Liver Cirrhosis, Biliary / Q000097:blood; D008107:Liver Diseases / Q000097:blood / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D014184:Transplantation, Homologous / Q000009:adverse effects; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
chemical_list: D001323:Autoantibodies; D016207:Cytokines; D006684:HLA-DR Antigens; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma